Instem PLC INS

Last Price
116.00
Day Change
0.00|0.00%

As of 24/05/2013
15:35:16 BST | GBX  Minimum 15 Minutes Delay.

Bid/OfferDay RangeVolume90d Ave VolMkt Cap
0.00 - 0.00112.00 - 119.502,443- 13.647
Last Close52 Week RangeP/EYield %ISIN
116.0081.00 - 160.0015.050.00GB00B3TQCK30

Instem Share Price

Total Returns

 Chg (%)  
3yr, 5yr & 10yr performance data is annualised.
Instem PLC7.91 
FTSE 100 TR GBP5.13
 
Financials
Annual
201020112012
more...
Income Statement
Turnover10.0010.7910.66
Operating Profit1.811.551.16
Net Profit0.901.011.04
Reported EPS11.708.508.90
Balance Sheet
Current Assets5.006.556.53
Non Current Assets6.908.578.95
Total Assets11.9015.1215.48
Current Liabilities5.877.847.29
Total Liabilities7.359.7110.48
Total Equity4.555.415.00
Cash Flow
Cash From Operations0.721.340.42
Change in Net Cash0.490.08-0.88
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
more...
'Broker Forecasts' provides consensus figures based on several brokers' views
20131.257.20-6.6016.11-2.44--
20141.619.1026.3912.750.48--

Regulatory News

Company Profile

Instem PLC is a provider of IT applications to the early development healthcare market. It offers pre-clinical study management solutions used in the early development healthcare market for the data collection, management, and analysis activities.

Sector

Technology

Industry

Health Information Services

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

112

Outlook

(29/04/2013) ch - "We believe that Instem is well positioned...and look forward to a positive 2013"

Next Event 19/09/2013

Next interim announcement
Ratios
 CompSecMkt
PER (E)14.6117.7013.93
Div Yld (E)-2.363.73
PEG (E)2.561.380.25
ROCE284.7743.43-20.93
Op Mrgn10.6931.28-54.21
EPS Grwth5.703.8316.34

Broker Forecasts

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
more...
Directors
more...
ChairmanDavid Gare
Chief Executive OfficerPhil Reason
Chief Financial Officer & Com SecNigel Goldsmith